Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research

Expanded laboratory capabilities support deeper mechanism-of-action research for stenoparib- New proteomics and cell line capabilities will broaden Allarity’s research capabilities to enable external partnershipsTARPON SPRINGS, Fla., September 28, 2026 — Allarity Therapeutics, Inc. (“Allarity” or…